Companies / PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc.

Nasdaq: PMVPCIK 1699382PRINCETON, NJ

Financials

Revenue—
Net income$-77.74M
Total debt—
Cash$39.13M
Diluted EPS$-1.48
Shares outstanding53.3M

Ownership

53.3M shares outstanding · as of May 12, 2026
15.7%10%+ / strategic
Ownership
10%+ / strategic15.72%8,382,093
Institutions68.63%36,599,605
Public float15.66%8,350,068

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Carulli MichaelChief Financial Officer
——
Gallagher Carol GiltnerDirector
——
Jalota DeepikaChief Development Officer
——
Levine Arnold JDirector
——
Mack David HenryCEOPresident and CEO · Director
——
Ticktin RobertGeneral Counsel & COO
——

Institutional holders 67

View all →
HolderValue% of shares
BML Capital Management, LLC$7.14M9.99%
Orbimed Advisors LLC$6.22M9.33%
Tang Capital Management, LLC$5.26M7.96%
ArrowMark Colorado Holdings, LLC$3.86M5.79%
Sio Capital Management, LLC$3.30M4.94%
Euclidean Capital LLC$3.28M4.93%
Vanguard Group Inc$2.71M4.07%
Two Sigma Investments, LP$2.34M3.53%
Adage Capital Partners Gp, L.L.C.$2.31M3.49%
Stonepine Capital Management, LLC$1.44M2.16%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 4, 2026Gallagher Carol Giltner
Director
GiftStock Option (right to buy)—+42K
42,000
0.08% of shares
low
Jun 4, 2026Gallagher Carol Giltner
Director
GiftStock Option (right to buy)—-42K
-100.00%
0
0.00% of shares
low
Jun 4, 2026Gallagher Carol Giltner
Director
GrantStock Option (right to buy)—+42K
42,000
0.08% of shares
low
Jun 4, 2026Levine Arnold J
Director
GrantStock Option (right to buy)—+42K
42,000
0.08% of shares
low
Mar 5, 2026Jalota Deepika
Executive
GrantEmployee Stock Option (right to buy)—+303K
303,310
0.57% of shares
low
Mar 5, 2026Carulli Michael
Executive
GrantEmployee Stock Option (right to buy)—+240K
240,000
0.45% of shares
low
Mar 5, 2026Ticktin Robert
Executive
GrantEmployee Stock Option (right to buy)—+319K
319,270
0.60% of shares
low
Mar 5, 2026Mack David Henry
CEO
GrantEmployee Stock Option (right to buy)—+745K
744,960
1.40% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
BML Investment Partners, L.P.Passive13G/A—5,292,000—
ArrowMark Colorado Holdings, LLCPassive13G/A—3,090,093—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PMVPCommon StockEquity69353Y103BBG007NM47G3